文献速递生殖医学妇科

青少年和年轻女性癌症幸存者后续不孕诊断风险:基于人群的队列研究

Risk of infertility in female adolescents and young adults with cancer: a population-based cohort study.
PubMed 文献 · Hum Reprod · 2021-01-01

该研究利用加拿大安大略省医疗数据库,纳入1992-2011年诊断的15-39岁常见癌症(脑、乳腺、结直肠、白血病、霍奇金淋巴瘤、非霍奇金淋巴瘤、甲状腺、黑色素瘤)且无复发生存≥5年的女性14316例,按年龄、人口普查分区和产次1:5匹配无癌症女性60975例,随访至2016年底。结果显示癌症幸存者不孕诊断风险总体升高(RR 1.30; 95%CI 1.23-1.37),乳腺癌、白血病、霍奇金淋巴瘤、非霍奇金淋巴瘤、甲状腺癌和黑色素瘤风险显著增加,脑和结直肠癌无显著关联。

要点

  • 年轻女性癌症幸存者不孕诊断风险总体升高30%。
  • 乳腺癌、白血病、淋巴瘤、甲状腺癌和黑色素瘤风险显著增加。
  • 脑和结直肠癌幸存者未观察到显著风险升高。

核心结论

  • 患有乳腺癌、血液系统肿瘤、甲状腺癌和黑色素瘤的青少年和年轻女性癌症幸存者后续不孕诊断风险更高。

主要发现

  • 癌症幸存者总体不孕诊断风险高于无癌症女性(RR 1.30; 95%CI 1.23-1.37)。
  • 乳腺癌(RR 1.46; 95%CI 1.30-1.65)、白血病(RR 1.56; 95%CI 1.09-2.22)、霍奇金淋巴瘤(RR 1.49; 95%CI 1.28-1.74)、非霍奇金淋巴瘤(RR 1.42; 95%CI 1.14-1.76)、甲状腺癌(RR 1.20; 95%CI 1.10-1.30)和黑色素瘤(RR 1.17; 95%CI 1.01-1.35)幸存者不孕诊断风险显著升高。
  • 按产次分层后,乳腺癌、白血病、淋巴瘤和黑色素瘤幸存者中经产女性关联减弱,而未产女性仍显著;甲状腺癌幸存者在未产和经产女性中均显著;脑和结直肠癌幸存者总体及分层后均无显著关联。

临床怎么用

  • 对年轻女性癌症幸存者,尤其乳腺癌、白血病和淋巴瘤患者,应优先开展生殖健康监测。

局限性

  • 行政数据库可能未捕获影响寻求生育评估的非生物学因素。
  • 癌症治疗等额外风险因素对关联的修饰效应需未来研究评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do female adolescents and young adults (AYAs) with cancer have a higher risk of subsequent infertility diagnosis than AYAs without cancer? SUMMARY ANSWER: Female AYAs with breast, hematological, thyroid and melanoma cancer have a higher risk of subsequent infertility diagnosis. WHAT IS KNOWN ALREADY: Cancer therapies have improved substantially, leading to dramatic increases in survival. As survival improves, there is an increasing emphasis on optimizing the quality of life among cancer survivors. Many cancer therapies increase the risk of infertility, but we lack population-based studies that quantify the risk of subsequent infertility diagnosis in female AYAs with non-gynecological cancers. The literature is limited to population-based studies comparing pregnancy or birth rates after cancer against unexposed women, or smaller studies using markers of the ovarian reserve as a proxy of infertility among female survivors of cancer. STUDY DESIGN, SIZE, DURATION: We conducted a population-based cohort study using universal health care databases in the province of Ontario, Canada. Using data from the Ontario Cancer Registry, we identified all women 15-39 years of age diagnosed with the most common cancers in AYAs (brain, breast, colorectal, leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, thyroid and melanoma) from 1992 to 2011 who lived at least 5 years recurrence-free (Exposed, n = 14,316). Women with a tubal ligation, bilateral oophorectomy or hysterectomy previous to their cancer diagnosis were excluded. We matched each exposed woman by age, census subdivision, and parity to five randomly selected unexposed women (n = 60,975) and followed subjects until 31 December 2016. PARTICIPANTS/MATERIALS, SETTING, METHODS: Infertility diagnosis after 1 year of cancer was identified using information on physician billing codes through the Ontario Health Insurance Plan database (ICD-9 628). Modified Poisson regression models were used to assess the risk of infertility diagnosis (relative risk, RR) adjusted for income quintile and further stratified by parity at the time of cancer diagnosis (nulliparous and parous). MAIN RESULTS AND THE ROLE OF CHANCE: Mean age at cancer diagnosis was 31.4 years. Overall, the proportion of infertility diagnosis was higher in cancer survivors compared to unexposed women. Mean age of infertility diagnosis was similar among cancer survivors and unexposed women (34.8 years and 34.9 years, respectively). The overall risk of infertility diagnosis was higher in cancer survivors (RR 1.30; 95% CI 1.23-1.37). Differences in infertility risk varied by type of cancer. Survivors of breast cancer (RR 1.46; 95% CI 1.30-1.65), leukemia (RR 1.56; 95% CI 1.09-2.22), Hodgkin lymphoma (RR 1.49; 95% CI 1.28-1.74), non-Hodgkin lymphoma (RR 1.42; 95% CI 1.14, 1.76), thyroid cancer (RR 1.20; 95% CI 1.10-1.30) and melanoma (RR 1.17; 95% CI 1.01, 1.35) had a higher risk of infertility diagnosis compared to women without cancer. After stratification by parity, the association remained in nulliparous women survivors of breast cancer, leukemia, lymphoma and melanoma, whereas it was attenuated in parous women. In survivors of thyroid cancer, the association remained statistically significant in both nulliparous and parous women. In survivors of brain or colorectal cancer, the association was not significant, overall or after stratification by parity. LIMITATIONS, REASONS FOR CAUTION: Non-biological factors that may influence the likelihood of seeking a fertility assessment may not be captured in administrative databases. The effects of additional risk factors, including cancer treatment, which may modify the associations, need to be assessed in future studies. WIDER IMPLICATIONS OF THE FINDINGS: Reproductive health surveillance in female AYAs with cancer is a priority, especially those with breast cancer, leukemia and lymphoma. Our finding of a potential effects of thyroid cancer (subject to over-diagnosis) and, to a lesser extent, melanoma need to be further studied, and, if an effect is confirmed, possible mechanisms need to be elucidated. STUDY FUNDING/COMPETING INTEREST(S): Funding was provided by the Faculty of Health Sciences and Department of Obstetrics and Gynecology, Queen's University. There are no competing interests to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Velez MP, Richardson H, Baxter NN, et al. Risk of infertility in female adolescents and young adults with cancer: a population-based cohort study. Hum Reprod. 2021. PMID: 33611573. doi:10.1093/humrep/deab036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。